Published Date: 09 Aug 2023
According to a group led by UT Southwestern Medical, loss of the SYNCRIP gene in prostate cancer tumors unleashes cellular machinery that leads to random mutations throughout the genome that increase resistance to targeted therapies.
Read Full NewsLong-acting injectable antipsychotics are linked to lower rehospitalization rates than oral antipsychotics in patients with bipolar I disorder, a study shows.
The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy in men with intermediate-risk prostate cancer.
1.
For incarcerated people, study shows gaps exist in quality of cancer care
2.
How a California Oncologist Making $850k Spends Money
3.
The most precise research tools for the deadliest blood cancer have been developed.
4.
Blinatumomab Plus Chemotherapy New Standard for Children With B-Cell ALL
5.
Big PFS Increase in Advanced Neuroendocrine Tumors With Combination Therapy
1.
Partial Gland Ablation in Prostate Cancer: Oncologic Outcomes in Intermediate-Risk Cases
2.
Navigating the Stages of Thyroid Cancer: A Guide for Patients
3.
Beyond the Blinders: A Review of Targeted Therapeutic Strategies for Triple-Negative Breast Cancer in 2025
4.
Understanding SVR Normal Range: A Guide to Achieving Optimal Health
5.
The Basics of M.C.V Normal Range for Better Health Management
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A New Era in Managing Cancer-Associated Thrombosis
2.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
3.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
4.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation